This was a federal case. The plaintiff was Otsuka Pharmaceutical Co Ltd, while the defendant was Jamp Pharma Corporation. This action involved the Patented Medicines (NOC) Regulations. The hearing was set on Dec. 12, 2023. No financial award was specified.